These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5855382)

  • 1. [Left heart insufficiency and its treatment with strophanthin, studied by graphic recording of cardiac contractions].
    Jezek V; Králová L; Teichmann V
    Sb Lek; 1965 Nov; 67(11):321-6. PubMed ID: 5855382
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative clinical studies of scillaglycoside A and k-strophanthin].
    Nusser E; Eberl R
    Med Welt; 1968 Feb; 9():454-7. PubMed ID: 5753203
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical assessment of the use of strophanthin and Nerobol in cardiac insufficiency].
    Polishchuk MA
    Klin Med (Mosk); 1970 Feb; 48(2):53-6. PubMed ID: 5425983
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of strophanthin and Corelborin II on the gaseous composition of the blood in chronic circulatory insufficiency].
    Volosianko BM; Kit SM
    Vrach Delo; 1969 Oct; 10():64-7. PubMed ID: 5366819
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of corelborin II and strophanthin on the activity of various enzymes in patients with chronic circulatory insufficiency].
    Kit SM; Volosianko BM
    Vrach Delo; 1972 Dec; 12():34-7. PubMed ID: 4659210
    [No Abstract]   [Full Text] [Related]  

  • 6. [Myocardial contractile function in acute heart failure during exposure to strophanthin and its combination with alpha-tocopherol].
    Chekman IS; Frantsuzova SB; Antonenko LI; Gudivok IaS
    Farmakol Toksikol; 1988; 51(4):44-7. PubMed ID: 3191972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of corelborine P, cymarin and strophanthin K on cardiovascular system of dogs with symptoms of cardiac insufficiency].
    Kit SM
    Farmakol Toksikol; 1967; 30(3):313. PubMed ID: 5597739
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiokinetic therapy in the aged. The role of strophanthin].
    Cavalieri U; Bonaccorso O
    Minerva Med; 1970 Feb; 61(15):700-4. PubMed ID: 5417562
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in cardiomyocytes in acute cardiac insufficiency as a result of administration of strophanthin and alpha-tocopherol].
    Gudivok IaS; Shutka BV; Gereliuk IP
    Vrach Delo; 1987 Oct; (10):53-6. PubMed ID: 3424735
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polygraphic studies before and after strophanthin therapy in subjects undergoing periodic dialytic treatment].
    Pasqualicchio A; Pasoli CA; Franzoni A; Ancona G; Bruschi E; Gianfranceschi G
    Fracastoro; 1969; 62(1):21-5. PubMed ID: 5402907
    [No Abstract]   [Full Text] [Related]  

  • 11. [Strophanthin therapy substituted for digitalis therapy].
    Kessler K
    Med Welt; 1970 May; 22():1048. PubMed ID: 5509758
    [No Abstract]   [Full Text] [Related]  

  • 12. [The influence of kordaron on the pharmacodynamic effects of strophanthin in experiments on isolated myocardial preparations and in the modelling of heart failure].
    Lemkina SM
    Eksp Klin Farmakol; 1993; 56(4):30-3. PubMed ID: 8220011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of the combination of strophanthin and ATP in the therapy of chronic circulatory insufficiency].
    Karbasnikova GN
    Sov Med; 1974 Aug; 0(8):90-4. PubMed ID: 4428283
    [No Abstract]   [Full Text] [Related]  

  • 14. [Central hemodynamic indices in chronic circulatory failure patients during strophanthin treatment].
    Sokolov AM
    Vrach Delo; 1983 May; (5):21-3. PubMed ID: 6880161
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of the action of a preparation of K-strophanthin for intramuscular use].
    Colombo L; Monarca A; Zanetta R
    Minerva Cardioangiol; 1978 Sep; 26(9):609-14. PubMed ID: 703962
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical studies of the oral and parenteral action of k-strophanthin-alpha in decompensated heart patients].
    Krämer KD; Ghabussi P; Hochrein H
    Dtsch Med Wochenschr; 1972 Jun; 97(22):870-7. PubMed ID: 4114343
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of strophanthin and certain biologically active substances on the indicators of cardiac rhythm in chronic circulatory insufficiency].
    Klykov NV; Trusov IuM; Poliakova LA; Ivanova NV
    Kardiologiia; 1974; 15(3):135-7. PubMed ID: 4838753
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epicritical views on the long-term management of cardiac insufficiency using Cyma in (Alvonal MR)].
    Russy W
    Landarzt; 1967 Nov; 43(33):1634-6. PubMed ID: 5594634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electroca rdiographic control in clinical use of mean therapeutic doses of cardiac glycosides (strophanthin, corglycon)].
    Fan-Tkhi-Ngok-Shiong
    Ter Arkh; 1974; 46(6):83-9. PubMed ID: 4473844
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of the glycoside strophanthin K on the ultrastructure of the cardiomyocytes in the pro-oxidant zone of the myocardium in rats with experimental heart failure].
    Chernysh IN; Sadovnikov VB
    Eksp Klin Farmakol; 1997; 60(4):29-31. PubMed ID: 9376752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.